Surprisingly, RIPK2 activity was elevated in the pre-neoadjuvant chemotherapy tumor tissues when compared to normal (p-value = 0.006) and immunohistochemical staining was significantly elevated in matched post-chemotherapy tissue (p-value < 0.0001) (Figure 4). Here, RIPK2 is linked to neoplasm.